DUBLIN--(BUSINESS WIRE)--The "Influenza Vaccines Market: Global Industry Analysis, Share, Size, Growth, Opportunity and Forecast 2019-2025" report has been added to ResearchAndMarkets.com's offering.
The global influenza vaccines market size is expected to surpass USD 6 billion by 2025.
Influenza Vaccines Market: Global Industry Analysis, Share, Size, Growth, Opportunity and Forecast 2019-2025 presents an in-depth assessment of the global influenza vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for the global influenza vaccines market. The report includes historical data from 2013 to 2018 and forecasts until 2025.
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025. The report provides clear insight into current and future developments of the global influenza vaccines market. The report also explores detailed analysis of the number of persons being vaccinated with influenza vaccines globally from 2013 to 2018 and forecasts to 2025.
Additionally, the report includes assessment of clinical trials, promising influenza vaccines in the clinical development and rapid diagnostic testing for the management of influenza. It also provides a deep and thorough evaluation of the distribution channel and technique of the influenza vaccination. Key trends in terms of collaboration, merger & acquisition, distribution, exclusive and licensing agreement are analyzed with details. The report also explores the detailed description of growth drivers and inhibitors of the global influenza vaccines market.
Further, prudent analysis has been done on the competitor's part, where four major players grab a major share of the global influenza vaccine market by net sales. Sanofi Pasteur, GlaxoSmithKline (GSK), Seqirus (CSL Limited) and AstraZeneca are the key influencers with their vaccines in the global influenza vaccines market. Other emerging players such as Novavax, Daiichi-Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, Altimmune, FluGen, Moderna, Vaccitech, VaxInnate, and BioDiem are making novel technology-based influenza vaccine which is likely to affect the market share during the forecast period.
The report concludes with the profiles of major players in the global influenza vaccines market. The key market players are evaluated on various parameters such as company overview, influenza vaccines portfolios, sales value analysis and recent development in the global influenza vaccines market.
The Latest Industry Data Included in this Report:
- Global Influenza Vaccines Market Size and Analysis (2013 - 2025)
- Global Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
- Global Influenza Vaccines Market Share Analysis and Forecast (2013 - 2025)
- Global Number of Persons Vaccinated with Influenza Vaccines Share and Forecast (2013 - 2025)
- Global Influenza Vaccines Market in Top 21 Countries and Forecast (2013 - 2025)
- Rapid Diagnostic Testing for the Management of Influenza
- Global Distribution Channel and Technique of Influenza Vaccination
- Promising Influenza Vaccines in Clinical Development
- Major Deals in the Global Influenza Vaccines Market
- Influenza Vaccines Clinical Trial Insights by Phase, Company & Country
- Market Definition for the Specified Topic Along with Identification of Key Drivers and Inhibitors for the Market
- A Comprehensive List of Key Market Players Along with the Analysis of their Current Vaccines Portfolios, Sales Value Analysis, and Recent Development
The Report Answers the Following Questions:
- How has the global influenza vaccines market performed so far and how will it perform in the coming years?
- What are the key markets in the global influenza vaccines industry?
- How many numbers of persons being vaccinated with influenza vaccines globally during 2013 - 2025?
- What are the key drivers and inhibitors in the current market?
- What are the various influenza vaccines available globally?
- How is the market predicted to develop in the future?
- Who are the key players in this market space?
Key Topics Covered
1. Executive Summary
2. Global Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
3. Global Influenza Vaccines Market Size and Analysis (2013 - 2025)
4. Global Influenza Vaccines Market Share Analysis and Forecast (2013 - 2025)
4.1 Global Number of Persons Vaccinated with Influenza Vaccines Share and Forecast
4.2 Global Influenza Vaccines Market Share and Forecast
5. Key Drivers and Inhibitors of the Global Influenza Vaccines Market
5.1 Market Drivers
5.2 Market Inhibitors
6. Global Influenza Vaccines Market in Top 21 Countries - Geographical Landscape (Volume and Value) (2013 - 2025)
6.1 United States
6.1.1 United States Number of Persons Vaccinated with Influenza Vaccines (2013 - 2025)
6.1.2 United States Influenza Vaccines Market Size & Analysis (2013 - 2025)
6.2 Canada
6.3 Germany
6.4 France
6.5 Italy
6.6 Spain
6.7 United Kingdom
6.8 Netherlands
6.9 Sweden
6.10 Denmark
6.11 Poland
6.12 Norway
6.13 Finland
6.14 Ireland
6.15 Belgium
6.16 Australia
6.17 New Zealand
6.18 Japan
6.19 Brazil
6.20 China
6.21 India
6.22 Other Countries
7. Rapid Diagnostic Testing for the Management of Influenza
8. Global Distribution Channel and Technique of Influenza Vaccination
9. Promising Influenza Vaccines in Clinical Development
10. Major Deals in the Global Influenza Vaccines Market
10.1 Merger& Acquisitions
10.2 Collaboration Deal
10.3 Licensing Agreement
10.4 Exclusive Agreement
10.5 Distribution Agreement
11. Influenza Vaccines Clinical Trial Insights by Phase, Company & Country
11.1 Year 2018
11.2 Year 2017
12. Key Companies Analysis
12.1 Sanofi Pasteur
12.1.1 Business Overview
12.1.2 Influenza Vaccines Portfolio
12.1.3 Influenza Vaccine Value Sales Analysis
12.1.4 Recent Development
12.2 GlaxoSmithKline (GSK)
12.3 Seqirus (CSL Limited)
12.4 AstraZeneca
12.5 Sinovac Biotech Ltd.
12.6 Gamma Vaccines Pty Ltd.
12.7 Hualan Biological Engineering Inc.
12.8 Shanghai Institute of Biological Products Co. Ltd.
12.9 Mylan
12.10 BioDiem
For more information about this report visit https://www.researchandmarkets.com/r/4efumg
